financetom
Market
financetom
/
Market
/
Eli Lilly, ConocoPhillips And 3 Stocks To Watch Heading Into Thursday
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Eli Lilly, ConocoPhillips And 3 Stocks To Watch Heading Into Thursday
Aug 7, 2025 1:01 AM

With U.S. stock futures trading higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows:

Wall Street expects Eli Lilly And Co. ( LLY ) to report quarterly earnings at $5.53 per share on revenue of $14.39 billion before the opening bell, according to data from Benzinga Pro. Eli Lilly ( LLY ) shares rose 1% to $753.53 in after-hours trading.

Analysts are expecting ConocoPhillips ( COP ) to have earned $1.40 per share on revenue of $14.63 billion for the latest quarter. The company will release earnings before the markets open. ConocoPhillips ( COP ) shares rose 0.3% to $93.39 in after-hours trading.

Corning Inc. ( GLW ) shares gained in Wednesday's after-hours session after the company announced an expanded partnership with Apple Inc. ( AAPL ) to make precision glass for Apple ( AAPL ) products. Corning shares surged 5.5% to $67.50 in the after-hours trading session.

Check out our premarket coverage here

Airbnb Inc. ( ABNB ) reported upbeat financial results for the second quarter on Wednesday after the bell. Airbnb ( ABNB ) expects third-quarter revenue of $4.02 billion to $4.1 billion. The company expects year-over-year growth of Nights and Experiences booked to be "relatively stable" in the third quarter compared to the second quarter. Airbnb ( ABNB ) shares dipped 5.9% to $122.74 in the after-hours trading session.

Analysts expect Block Inc. ( XYZ ) to post quarterly earnings of 68 cents per share on revenue of $6.25 billion after the closing bell. Block shares rose 0.1% to $76.20 in after-hours trading.

Check This Out:

Top 2 Industrials Stocks That May Plunge In August

Photo via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Financial
Sector Update: Financial
Mar 21, 2024
03:19 PM EDT, 03/21/2024 (MT Newswires) -- Financial stocks advanced late Thursday afternoon, with the NYSE Financial Index and the Financial Select Sector SPDR Fund (XLF) each rising 0.9%. The Philadelphia Housing Index climbed 1.8%, and the Real Estate Select Sector SPDR Fund (XLRE) was adding 0.4% Bitcoin (BTC-USD) dropped 4% to $65,176, and the yield for 10-year US Treasuries...
Japan's Nikkei hits record high on Wall Street gains, weaker yen
Japan's Nikkei hits record high on Wall Street gains, weaker yen
Mar 21, 2024
TOKYO, March 22 (Reuters) - Japan's Nikkei share average hit a record high on Friday, underpinned by the strength on Wall Street overnight and as a weaker yen prompted investors to buy automakers. The Nikkei rose to as high as 41,087.75 earlier in the session, crossing the 41,000 level for the first time. The index ended 0.07% higher at 40,844.53...
Japan's Nikkei ends at record high on Wall Street gains, weaker yen
Japan's Nikkei ends at record high on Wall Street gains, weaker yen
Mar 22, 2024
(Updates to closing prices) TOKYO, March 22 (Reuters) - Japan's Nikkei share average closed at an all-time high on Friday, underpinned by record gains on Wall Street overnight and strength in automakers' stocks on a weaker yen. The Nikkei rose 0.18% to end at 40,888.43, after hitting 41,087.75 earlier in the session to break an all-time intraday high. The index,...
Sector Update: Health Care
Sector Update: Health Care
Mar 21, 2024
03:42 PM EDT, 03/21/2024 (MT Newswires) -- Health care stocks rose late Thursday afternoon with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) rising 0.3%. The iShares Biotechnology ETF (IBB) climbed 0.9%. In corporate news, Eledon Pharmaceuticals ( ELDN ) shares surged 12% after it said its tegoprubart monoclonal antibody was used...
Copyright 2023-2026 - www.financetom.com All Rights Reserved